Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Buy

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Sell

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Ocean Biomedical, Inc. Common Stock (OCEA)

Pharmaceutical Preparations

https://www.oceanbiomedical.com

Ocean Biomedical Inc is a biopharmaceutical company. It is dedicated towards partnering with inventor-scientists and research institutes to bridge the gap between basic research and clinical development, to get new medicines to the patients who need it most.

515 MADISON AVE SUITE 8078
NEW YORK, NY

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

02/08/2023

Market Cap

36,731,456

Shares Outstanding

34,070,000

Weighted SO

34,087,201

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

ENVB --.--%

HEPA --.--%

ELEV --.--%

AVRO --.--%

CWBR --.--%

ZURA --.--%

EFTR --.--%

Beta

1.5430

Last Div

0.0000

Range

0.52-7.79

Chg

-0.0299

Avg Vol

133611

Mkt Cap

36731456

Exch

NASDAQ

Country

US

Phone

401-444-7375

DCF Diff

1.1979

DCF

-0.1377

Div Yield

0.0000

P/S

0.0000

EV Multiple

-2.0551

P/FV

-0.3749

Div Yield %

0.0000

P/E

-0.1818

PEG

-0.0018

Payout

0.0000

Current Ratio

0.0334

Quick Ratio

0.0334

Cash Ratio

0.0334

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

0.0000

CCC

0.0000

Gross Margin

0.0000

Op Margin

0.0000

Pretax Margin

0.0000

Net Margin

0.0000

Eff Tax Rate

-0.6490

ROA

-150.4861

ROE

5.6707

ROCE

0.3541

NI/EBT

1.6415

EBT/EBIT

8.9521

EBIT/Rev

0.0000

Debt Ratio

11.6887

D/E

-0.1602

LT Debt/Cap

0.0000

Total Debt/Cap

-0.1908

Int Coverage

-4.2165

CF/Debt

-0.7106

Equity Multi

-0.0137

Rec Turnover

0.0000

Pay Turnover

0.0000

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0000

OCF/Share

-0.3219

FCF/Share

-0.3219

Cash/Share

0.0388

OCF/Sales

0.0000

FCF/OCF

1.0000

CF Coverage

-0.7106

ST Coverage

-0.7106

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

-0.3749

P/B

-0.3749

P/S

0.0000

P/E

-0.1818

P/FCF

-4.2896

P/OCF

-3.2937

P/CF

-3.2937

PEG

-0.0018

P/S

0.0000

EV Multiple

-2.0551

P/FV

-0.3749

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Nov 22, 21:45 Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q GlobeNewswire Inc. Nov 29, 17:41 Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q GlobeNewswire Inc. Nov 29, 17:41 Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q GlobeNewswire Inc. Oct 26, 05:30 Ocean Biomedical (NASDAQ: OCEA) Announces First Patients Dosed by Joint Venture Partner Virion Therapeutics in Phase 1b Study of Novel Immunotherapy for Chronic Hepatitis B Virus Infection

Revenue Product Segmentation